Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients

Journal of the American Society of Nephrology

Volumn 22, Issue 2, 2011, Pages 358-365

  Goodkin, David A ^a   Fuller, Douglas S ^a   Robinson, Bruce M ^a   Combe, Christian ^b   Fluck, Richard ^c   Mendelssohn, David ^d   Akizawa, Tadao ^e   Pisoni, Ronald L ^a   Port, Friedrich K ^a  

^a ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK FACTOR; SCORING SYSTEM; SMOKING;

EID: 79551678083     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010020173     Document Type: Article

References (32)

1. Charles G, Lundin AP III, Delano BG, Brown C, Friedman EA: Absence of anemia in maintenance hemodialysis. Int J Artific Organs 4: 277-279, 1981
2. Iorio BD, Iodice C: High hemoglobin in dialysis patients not receiving rHuEPO. Am J Kidney Dis 40: 1349, 2002
3. Kuo CC, Lee CT, Chuang CH, Su Y, Chen JB: Recombinant human erythropoietin independence in chronic hemodialysis patients: Clinical features, iron homeostasis and erythropoiesis. Clin Nephrol 63: 92-97, 2005 (Pubitemid 40298043)
4. Young EW, Goodkin DA, Mapes DL, Port FK, Keen ML, Chen K, Maroni BL, Wolfe RA, Held P: The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney Int 57: S74-S81, 2000
5. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA: The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology. Am J Kidney Dis 44[Suppl 2]: 7-15, 2004
6. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR, Korbet S, Krantz SB, Lundin AP, Nissenson AR, Ogden DA, Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB, Zuckerman K, Adamson JW: Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992-1000, 1989
7. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held P, Port FK: Anemia management and outcomes from 12 countries in the Dialysis and Practice Patterns Study (DOPPS). Am J Kidney Dis 44: 94-111, 2004 (Pubitemid 38880932)
8. Krapf R, Hulter HN: Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA). Clin J Am Soc Nephrol 4: 470-480, 2009
9. Smith JR, Landaw SA: Smokers' polycythemia. N Engl J Med 298: 6-10, 1978
10. Floege J, Eitner F: Acquired cystic kidney disease and malignancies in chronic kidney disease. In: Comprehensive Clinical Nephrology, edited by Feehally J, Floege J, Johnson RJ, Philadelphia, Mosby Elsevier, 2007, pp 911-916
11. Shalhoub RJ, Rajan U, Kim VV, Goldwasser E, Kark JA, Antoniou LD: Erythrocytosis in patients on long-term hemodialysis. Ann Intern Med 97: 686-690, 1982
12. Goldsmith HJ, Ahmad R, Raichura N, Lai SM, McConnell CA, Gould DA, Gyde OH, Green J: Association between rising haemoglobin concentration and renal cyst formation in patients on long term regular haemodialysis treatment. Proc Eur Dial Assoc 19: 313-318, 1983
13. Glicklich D, Kutcher R, Rosenblatt R, Barth RH: Time-related increase in hematocrit on chronic hemodialysis: Uncertain role of renal cysts. Am J Kidney Dis 15: 46-54, 1990 (Pubitemid 20086580)
14. Eschbach JW: Anemia management in chronic kidney disease: Role of factors affecting epoetin responsiveness. J AmSoc Nephrol 13: 1412-1414, 2002
15. Eckardt KU, Möllmann M, Neumann R, Brunkhorst R, Burger HU, Lonnemann G, Scholz H, Keusch G, Buchholz B, Frei U, Bauer C, Kurtz A: Erythropoietin in polycystic kidneys. J Clin Invest 84: 1160-1166, 1989
16. Rao DS, Shih M, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328: 171-175, 1993
17. Takeda A, Toda T, Shinohara S, Mogi Y, Matsui N: Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin. Am J Kidney Dis 40: 104-109, 2002
18. Aucella F, Scalzulli RP, Gatta G, Vigilante M, Carella AM, Stallone C: Calcitriol increases burst-forming unit-erythroid proliferation in chronic renal failure: A synergistic effect with r-HuEpo. Nephron Clin Pract 95: c121-c127, 2003
19. Neves PL, Trivino J, Casaubon F, Santos V, Mendes P, Romao P, Bexiga I, Bernardo I: Elderly patients on chronic hemodialysis with hyperparathyroidism: Increase of hemoglobin level after intravenous calcitriol. Int Urol Nephrol 38: 175-177, 2006
20. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW: Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105: c132-c138, 2007
21. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17: 1181-1191, 2006
22. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
23. Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, Patel UD, Singh AK: Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes. Kidney Int 74: 791-798, 2008
24. Furuland H, Linde T, Ahlmén J, Christensson A, Strömbom U, Danielson BG: A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 18: 353-361, 2003
25. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, for the CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006
26. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, for the TREAT Investigators: A trial of darboepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
27. Foley RN, Curtis BM, Parfrey PS: Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial. Clin J Am Soc Nephrol 4: 726-733, 2009
28. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, for the CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
29. National Kidney Foundation: K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50: 474-530, 2007
30. Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R: Anaemia management in patients with chronic kidney disease: A position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24: 348-354, 2009
31. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB: Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 3: 329-338, 1994
32. Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 14: 3270-3277, 2003